Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

Experts warn of an expected winter COVID-19 surge, potentially impacting marginalized communities that have faced disproportionate effects since the pandemic began. Health advocates emphasize the need ...

Kennedy Jr. has not been a big fan of the vaccines, to say it mildly… Pfizer, which picked up some potentially revolutionary ...

Shares of vaccine makers such as Moderna (MRNA) and Pfizer (PFE) have plunged on news that president-elect Donald Trump has ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...